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Abstract  Plantar fasciitis (PF) is the most common cause of heel pain today impacting on the patient’s walking ability, 
work tolerance, and ability to participate in active sport. Two million people in the United States (US) are treated for PF 
yearly with heel pain accounting for 11 to 15% of visits to medical professionals. It is estimated that 10% of the US 
population will develop PF during their lifetime. Treatment for PF may include a variety of interventions ranging from 
conservative treatment to surgical interventions. One of the suggested treatments for PF is the use of extracorporeal 
shockwave therapy (ECSWT). ECSWT is a relatively new therapeutic modality that has been used in the treatment of PF and 
a variety of other musculoskeletal disorders with some success reported. Normally healthcare providers do not treat with the 
use of only one modality or treatment approach but rather a combination of treatments in an attempt to obtain a desired 
positive effect on the patient. The research available on the use of ECSWT is limited in that it has not been determined 
whether this modality used in isolation, or in combination is the most effective. Research has been conducted comparing 
ECSWT to placebo and a variety of controls but the effectiveness of combinations of treatment has not been studied. 
Therefore, the purpose of this study was to compare the effects of ECSWT alone, to ECSWT and joint mobilization, and 
ECSWT and exercise, on heel pain in patients with PF, as measured by the visual analog scale (VAS) and Lower Extremity 
Functional Scale (LEFS). Subjects (N=75) were randomly assigned into 3 groups: ECSWT, ECSWT and joint mobilizations 
to the talocrural, subtalar, and first metatarsophalangeal (MTP) joint, or ECSWT and stretching for the gastrocnemius, soleus, 
and plantar fascia and strengthening for the ankle. Subjects received three treatments in total spaced one week apart. A VAS 
for pain and LEFS were measured pre-treatment and three months post-treatment. All groups demonstrated statistically 
significant improvement over time in all VAS scores and in the LEFS (P<.05). There was a statistically significant difference 
in VAS for heel pain following activity between the ECSWT and joint mobilization group and ECSWT and exercise group 
(F= 3.577, p= .033) with a greater reduction in pain in the ECSWT and joint mobilization group. Further research is required 
using an alternative study design to compare the combinations of treatment to a control or placebo group. The findings of this 
study, however, indicate that if ECSWT is going to be combined with another treatment, then the combination of ECSWT and 
joint mobilization may be more effective than combining ECSWT with exercise.  
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1. Introduction 
Plantar fasciitis (PF) is the most common cause of heel 
pain today with 10% of the population in the United States 
(US) developing it in their lifetime[11, 20, 43]. The 
functional implications of this disorder result in decreased 
walking tolerance, the inability to complete daily functional  
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and work related tasks and the inability to participate in 
active exercise and sport. Two million people are treated for 
PF in the US yearly with heel pain accounting for 11 to 15% 
of visits to medical professionals (physicians, 
physiotherapists, chiropractors and athletic therapists)[11, 20, 
43]. Although the exact causes of PF are unknown, it is felt 
that PF may be associated with several factors including 
overuse, poor intrinsic muscle strength, over pronation and 
various foot deformities[7, 10, 27, 48]. Other risk factors 
also include increased age, increased body mass index (BMI) 
greater than 30kg/m2, increased height and weight, decreased 
ankle dorsiflexion and decreased first metatarsophalangeal 
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(MTP) joint range of motion (ROM)[29, 53, 56, 58]. 
Questions regarding whether PF is an inflammatory 
condition with prostaglandin mediated inflammation, or 
rather a degenerative condition have arisen and may impact 
on treatment decisions[23]. PF often does not respond to 
typical treatments that are used for acute inflammatory 
conditions and this may be partly due to the lack of 
inflammatory mediators present. Typical treatments for PF 
include interventions ranging from conservative to surgical. 
The use of non-steroidal anti-inflammatory medications 
(NSAIDS), therapeutic modalities such as ultrasound 
therapy, laser and interferential current, orthotics, nights 
splints and a variety of taping techniques have been proposed 
with mixed results reported[33]. Short term relief has been 
reported with the combination of NSAIDS delivered via 
iontophoresis or with the use of custom or pre-fabricated 
orthotics or night splints[33, 61]. Other proposed treatments 
include the use of manual therapy and stretching and 
strengthening exercises[3, 9, 12, 15, 23, 26, 30, 33, 36, 44, 45, 
59]. Stretching exercises for the gastrocnemius, soleus and 
plantar fascia have been shown to provide short term pain 
relief lasting only a few hours to a few days[18, 31, 39, 40, 
47, 49]. It has been recommended that the calf muscle 
stretches should be held for 30 second holds and performed 
for 3-5 repetitions per day[18, 40, 49]. Longer relief has been 
reported in patients treated with fascial specific stretching 
exercises[13, 16, 52]. Stretching and mobilizations of the 
first MTP into dorsiflexion as well, may be beneficial[14]. 
There has been limited, high quality studies performed on the 
use of manual therapy as an intervention for PF. Suggested 
mobilizations to the talocrural, subtalar and first MTP joints 
have been recommended but the evidence to support the use 
of manual therapy to these articulations is contradictory[33, 
34, 60]. Some studies have reported that combinations of 
treatment may be the optimal treatment choice for patients 
with PF. For example, combining manual therapy with 
exercise may be more effective than combining 
electrotherapeutic modalities and exercise[9].  
Drake et al[16] examined the effects of stretching 
compared to custom foot orthotics in 15 patients with PF. 
Stretches consisted of plantar fascial, gastrocnemius and 
soleus stretches and general ROM exercises first thing in the 
morning. Significant improvement was demonstrated with 
both the use of orthotics and stretching[16]. Renan Ordine et 
al[40] also examined the effect of myofascial trigger point 
therapy versus stretching exercises on patients with plantar 
heel pain. Sixty patients were randomly assigned to either the 
stretching group or the stretching and manual therapy group. 
Self-stretching exercises consisted of gastrocnemius, soleus 
and plantar fascial stretches while the manual therapy group 
consisted of trigger point pressure and longitudinal stroking 
over the gastrocnemius muscle. Clinically significant 
improvement was evident with the combination of stretching 
and manual soft tissue techniques[40]. 
Extracorporeal shockwave therapy (ECSWT) is a new 
therapeutic modality that has been used in the treatment of 
acute and chronic PF and a variety of other musculoskeletal 
conditions with varied success reported[5, 6, 50]. The exact 
physiological affect and mechanism on healing is unknown 
but several hypotheses exist. A shockwave unit generates 
soundwaves at a frequency of 10-15 Hz causing cavitation 
bubbles and a water jet effect which creates microscopic 
holes and hemorrhaging in the plantar fascia. This initiates a 
local inflammatory reaction and chemical changes[41]. 
These physiological effects have been proposed to be 
beneficial in the treatment of the chronic and degenerative 
changes present in the tissue of the plantar fascia[7, 21]. 
Other hypotheses on the affects of ECSWT include the 
degeneration of axons and sensory nerves, the activation of 
the Gate Control Theory, the chemical alteration of receptor 
neurotransmitters and cell mediums and reduced production 
of inflammatory mediators, calcitonin gene related peptide 
and substance P[21, 22, 32, 37, 46]. Once again, these 
proposed benefits may help reduce pain and initiate healing 
in the plantar fascia. 
Studies examining the effectiveness of ECSWT in patients 
with PF have reported positive treatment effects in 
decreasing pain and improving function with success ranging 
from 50 to 90% with a low recurrence rate of 5 to 7%[14, 29]. 
A systematic review and meta-analysis on the effectiveness 
of ECSWT in the treatment of plantar heel pain, however, 
has reported mixed findings and the studies that did find 
positive results had a small effect size[54]. 
Gollwitzer et al[21] examined the effects of ECSWT on 
40 patients with PF. Patients were randomly assigned to 
either the ECSWT group or the sham group. The ECSWT 
treatment protocol consisted of three sessions of 2000 
electromagnetic generated shockwaves spaced one week 
apart. A visual analog scale (VAS) was used to compare the 
effects of the treatments. Significant improvement was noted 
in the ECSWT group as compared to the sham treatment 
group[21]. Gerdesmeyer et al[20] also examined the effects 
of radially generated ECSWT versus placebo in a very large 
study with 245 patients with chronic PF. Clinically 
significant improvement in the VAS scores and in the 
functional scale scores was evident in the ECSWT group 
compared to the placebo group. Overall success rate was  
61% compared to 42% in the placebo group[20].  
In another large retrospective study of 225 patients with 
chronic PF who were treated with ECSWT, Chuckpaiwong 
et al[7] reported success rates of 71% at three months post 
treatment and 77% at twelve months post treatment. Similar 
positive findings were reported in Cheing’s study comparing 
ECSWT and ultrasound therapy on plantar heel pain as 
measured with the VAS and functional tolerances for 
standing and walking[6]. Several authors have summarized 
the use of ECSWT in the treatment of PF and have described 
the common use of the VAS in combination with other 
functional measures to analyse the effects of the treatment. 
Common parameters used in the treatment protocols cited 
was 2000 shockwaves applied to the painful region and 
treated three times per week, spaced one week apart[6, 12]. 
Wang et al[55] examined the long term effects of ECSWT 
on 168 patients with chronic PF compared to patients having 
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NSAIDS, orthotics, physical therapy and exercise using a 
100 point scoring system for pain and a VAS. The ECSWT 
group demonstrated excellent results in 69.1% of the cases 
compared to 0% in the control group. Malay et al[32] 
examined the effects of ECSWT on 172 patients compared to 
a placebo group with a single treatment. VAS scores were 
significantly improved in the shockwave group in 
comparison to the placebo group at three months and 12 
months post treatment. Rompe et al[44] compared the effects 
of plantar fascial specific stretching to ECSWT on 102 
patients with PF. They reported that patients that received 
plantar fascial specific stretching demonstrated significant 
improvement in acute pain and symptoms when compared to 
the ECSWT group alone. Looney et al[31] compared the 
combined effects of a home stretching program for the calf 
muscles and plantar fascia and the use of soft tissue 
mobilization using a Graston Instrument on the numerical 
pain rating scale, Lower Extremity Functional Scale (LEFS) 
and Global Rating of Change Scale in 10 patients with PF. 
All patients demonstrated a significant improvement at the 
eight week follow up with the combined treatment 
interventions[37]. 
1.1. Clinical Justification and Purpose 
The use of ECSWT continues to expand clinically. As 
highlighted previously, several studies have examined the 
effects of ECSWT in isolation for PF, or in comparison to 
placebo and sham treatments, but rarely in combination with 
other treatments. Healthcare providers (physiotherapists, 
athletic therapists, chiropractors) normally do not treat with 
only one modality or treatment approach but rather a 
combination of treatments. Therefore, the purpose of this 
study was to assess the effects of ECSWT in isolation 
compared to ECSWT combined with either joint 
mobilizations or exercise on plantar heel pain in patients 
with PF as measured by the VAS and LEFS. It was 
hypothesized that ECSWT combined with either exercise or 
joint mobilizations would have a more positive effect on 
function and heel pain than ECSWT alone as measured by 
the LEFS and VAS. 
2. Methods 
2.1. Subjects 
This randomized clinical trial pre-test post-test design 
included 75 subjects divided into three treatment groups. The 
treatment groups consisted of either ECSWT, ECSWT and 
joint mobilizations to the talocrural, subtalar, and first MTP 
joint, or ECSWT and stretching exercises for the 
gastrocnemius, soleus and plantar fascia and strengthening 
for the ankle. Prior to recruiting subjects, ethical approval for 
the study was obtained by the university Research Ethics 
Board.  
The sample of convenience was recruited over a one year 
period of time from an urban, private, outpatient 
physiotherapy clinic. Eighty-five patients diagnosed with PF 
were referred by their physician into the study. The primary 
investigator, a registered physiotherapist, screened each 
patient for inclusion and exclusion criteria. Three 
participants did not meet the inclusion criteria and seven did 
not consent to participate in the study.  
All participants were between the ages of 22 and 68 years. 
All participants met the following inclusion criteria: (1) had 
unilateral foot pain localized to the heel, anteromedial 
calcaneal tubercle, body of the fascia or medial arch; (2) had 
heel pain in the morning with the first few steps and; (3) had 
heel pain after getting up after prolonged sitting, walking or 
running. Participants were excluded from the study if they 
met the following exclusion criteria: (1) had previous 
surgery to the plantar fascia; (2) had any other form of 
treatment during the study period excluding the intervention 
assigned; (3) had a history of foot fracture or congenital 
deformity of the foot; (4) used an assistive device such as an 
ankle foot orthoses; (5) had bilateral heel pain; (6) had any 
contraindications such as vascular or neurological disorders 
of the feet, pregnancy, implanted metal, or were taking 
NSAIDS, aspirin or coumadin. 
2.2. Outcome Measures 
The primary outcome measure commonly used in studies 
examining the effectiveness of various treatments for PF 
include the VAS and the LEFS[6, 7, 8, 9, 20, 21, 31, 32, 55]. 
Thus, the intensity of heel pain at rest, after activity, and 
overall improvement in heel pain, were assessed using a 100 
mm horizontal linear VAS. The self-report VAS has 
evidence of good validity, reliability and psychometric 
properties, and has been validated as a reliable measure for 
pain in musculoskeletal disorders[25, 51]. The pooled 
coefficients for the VAS ranges from .73-.80 for test-retest 
reliability and the pooled value for construct validity 
from .82-.94[25, 51]. The minimally clinically significant 
difference for the VAS score is a change of 30 millimeters on 
a 100 millimeter VAS[25, 51]. Pain, however, is a complex, 
subjective and multi-dimensional sensation. As highlighted 
previously, this dependent variable is commonly used in the 
analysis of pain but we must also consider the practical 
difficulties of its use. This outcome measure must be 
administered electronically or on paper; when using paper 
scales it must be insured that the length of the line is in fact 
not distorted in length by copying or printing; and lastly, the 
orientation of the scale (horizontal versus vertical) may 
produce varied results among different users[28, 57]. As a 
result, a horizontal VAS scale was used in the current study 
and we insured that no distortion was present and that the 
scale was in fact 100 mm in length. Subjects filled out the 
VAS and were asked to consider the following questions: (1) 
their level of heel pain at rest; (2) their level of heel pain 
following activity and; (3) how much better their heel pain 
was at that time compared to the initial onset. The amount of 
pain was estimated by measuring in millimeters the distance 
from the “no pain” marker to the mark provided by the 
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subject. 
Secondary outcomes in this study included overall 
functional abilities. Functional ability was assessed using the 
LEFS. The LEFS has evidence of good psychometric 
properties, validity and reliability. The LEFS has an internal 
consistency ranging from α = .90-.96, test–retest reliability 
ranging from .88-.94, and minimal detectable change and 
minimally clinical significant differences of nine[4, 8, 58]. 
The LEFS is useful with either acute or chronic impairment, 
is sensitive to change over time, and can be used in subjects 
of all ages and functional levels[4, 8, 58]. 
2.3. Data Collection and Test Procedures 
The principal investigator, who was a student completing 
this study in partial fulfillment of his doctoral degree, 
obtained voluntary consent from subjects, assessed, and 
randomly assigned each subject to a treatment group; thus, 
there was no blinding to group or treatment of the principal 
investigator. Once the randomization process was completed, 
anthropometric measures, strength, ROM, accessory 
movement and stability testing of the foot was performed.  
Subjects in group one received only ECSWT. Treatment 
consisted of 2000 shockwaves at an intensity of 2.5 bars, 
10-15 Hz and 11.5 Mp using a D Actor 100 Radial 
Shockwave Unit developed by Storz Medical[8]. The 
applicator was positioned over the painful site and plantar 
fascia. Subjects received three treatments in total spaced one 
week apart over a three week period.  
Subjects in group two received ECSWT as described 
previously and joint mobilizations. Mobilizations included 
posterior glides of the talus on the tibia to increase talocrural 
dorsiflexion, lateral glides of the calcaneous on the talus at 
the posterior subtalar to increase supination, and dorsal 
glides of the first proximal phalanx on the first metatarsal to 
increase MTP extension of the first ray. Mobilizations 
consisted of three sets of grade II and three sets of III 
oscillations as described by Maitland, performed for 30 
seconds[24]. These mobilizations were chosen as over 
pronation, decreased ankle dorsiflexion and decreased first 
MTP joint ROM have been described as contributing risk 
factors for PF[7, 10, 11, 27, 29, 44, 48, 53, 56]. The goal of 
these mobilization techniques was to increase ROM, thereby, 
reducing stress on the plantar fascia. Each subject received 
three treatments in total spaced one week apart over a three 
week period of time and included both ECSWT and 
mobilizations. Subjects in group two were not prescribed any 
therapeutic exercises (stretching or strengthening). 
Subjects in group three received ECSWT as described 
previously and stretching exercises for the gastrocnemius, 
soleus and plantar fascia, and ankle strengthening. Calf 
muscle and plantar fascial stretches were held for 30 seconds 
with three repetitions performed three times per day[31, 47]. 
Three sets of ten repetitions of strengthening exercises for 
the ankle with theraband and towel exercises for the intrinsic 
foot muscles were performed three times per day. Exercise 
parameters including frequency, repetitions and sets were 
based upon Rhea et al[42] and the American College of 
Sports Medicine guidelines[1,2]. These stretches were 
chosen as decreased dorsiflexion has been identified as a 
possible cause of PF[7, 11, 27, 29, 56]. When these 
stretching exercises have been used, good relief in heel pain 
has been reported[18, 31, 39, 40, 47, 49]. Longer term relief 
has been reported in patients that were also treated with 
plantar fascial stretching[13, 16, 52]. As a result, the 
combination of these exercises were used. Subjects received 
three treatments in total spaced one week apart over a three 
week period of time. During each treatment subjects 
received ECSWT. The exercises were performed 
independently at home but the exercise details were 
reviewed each week at the treatment session to formally 
check and review compliance with the exercise and 
encourage the participants to complete the program 
appropriately. No other form of exercise compliance was 
monitored and no level of non-compliance was established to 
disqualify participants from the study (figure 1). 
 
85 patients diagnosed with PF and screened           
for inclusion criteria 
 
 
 
 
 
 
 
Randomized n=75 
 
 
Group 1, n=25 Group 2, n=25 Group 3, n=25 
 
 
Assessed, baseline VAS and LEFS 
 
 
Group 1 
ECSWT 
3 treatments of 
ECSWT (spaced 
1 week apart) 
over 3 week 
period of time 
Group 2 
ECSWT and  
ankle and foot 
mobilizations 
3 treatments of 
ECSWT and  
joint mobilization 
(spaced 1 week 
apart) over 3 week 
period of time 
Group 3 
ECSWT     
and exercise 
3 treatments of 
ECSWT and 
exercise (spaced 
1 week apart) 
over 3 week 
period of time 
 
 
3 months follow up VAS and LEFS 
Group 1, n=25 Group 2, n=25 Group 3, n=25 
 
Figure 1.  Study design flowchart 
All subjects were treated individually by the principal 
investigator, a physiotherapist with 20 years of clinical 
Excluded n=10 
3 did not meet criteria 
7 did not consent to participate 
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experience and a Fellow of the Canadian Academy of 
Manual Physiotherapists. Subjects had no contact or 
knowledge of the identity of any other participants. Each 
session lasted approximately 30-60 minutes. All baseline and 
follow-up measurements and treatment sessions were carried 
out by the principal investigator. All subjects were also 
instructed to avoid NSAIDS or aspirin products for the 
duration of the study.  
Pre-test measures for the LEFS and VAS were taken prior 
to the initial assessment. These variables were also 
reassessed during each individual treatment session and then 
reassessed at three months post-treatment. For analysis, only 
the pre and 3 months post measures were used. All subjects 
participated in each treatment and testing session and no 
adverse events or dropouts occurred in the study. 
2.4. Sample-Size Calculation 
The sample-size calculation for analysis of variance 
(dfb=2) for VAS score utilized a change of 30 mm as the 
minimal clinically significant difference (MCSD) on a 100 
mm scale. A study by Williamson and Hoggart[57] found 
that repeat measures with the VAS could vary by 20%. Thus, 
with the significance level set at .05, a standard deviation 
(SD) of 20 mm was used to achieve a power level of 85% for 
an estimated 21 subjects per group. 
The sample-size calculation for a 2-tailed test for VAS 
score utilized a change of 30 mm as the minimal clinically 
significant difference (MCSD) on a 100 mm scale with a 
standard deviation (SD) of 20 mm. To achieve a power level 
of 90% with the significance level set at .05, 25 subjects per 
group were needed. 
2.5. Statistical Analysis 
SPSS Version 20.0 (SPSS Inc., Chicago, IL) was utilized 
to analyze means, SD and 95% confidence interval (CI) for 
the descriptive characteristics of the cohort and for pre and 
post changes within and between treatment groups. The 
Kolmogorov-Smirnov test for normality was used and was 
not significant revealing a normal distribution of the data. A 
One-way ANOVA was used to determine if there was a 
difference between treatment groups for the VAS and LEFS. 
If significance was found a Tukey post-hoc test was used to 
identify where the difference lies. Cohen’s d was used to 
calculate effect size with .8 being large, .5 medium, and .2 
small. A dependent T-test was used to determine if there was 
a significant change from pre to post scores for the VAS and 
LEFS scores within each group. For all analyses the alpha 
level was set at .05. 
3. Results 
The sample consisted of 75 subjects (22 males and 53 
females) with a mean age of 47 years with each subject 
randomized into one of three groups, ECSWT (n=25), 
ECSWT and joint mobilizations (n=25), and ECSWT and 
exercise (n=25). Descriptive data for height, weight, and 
BMI is summarized in Table 1. All groups improved over 
time in all VAS scores and in the LEFS (Table 2). 
The baseline score was subtracted from the final score to 
obtain a change value for each appropriate dependent 
variable. A One-way ANOVA was run to determine if there 
was a statistically significant difference in the pain levels 
between treatment groups for the LEFS score and VAS of 
pain at rest, with activity, and pain improvement (see Figures 
2-5). There was a statistically significant difference between 
groups for pain levels with activity (F (2, 72)= 3.577, 
p= .033). Effect size was calculated using Cohen’s d =.655 
which demonstrated a large effect size, yielding a 99% 
power. The Tukey post hoc test identified a difference 
between the ECSWT and mobilization and ECSWT and 
exercise group. The mean VAS score for pain after activity 
was significantly lower for ECSWT and mobilization 
compared to ECSWT and exercise (Table 2). No other 
statistical significance was found between groups for any of 
the other dependent variables. 
 
Figure 2.  LEFS scores by treatment group pre-treatment and 
post-treatment (mean pre and post LEFS scores contained in text box within 
columns; pre-treatment LEFS score ; post-treatment LEFS score ;) 
Table 1.  Demographic Information for all Subjects 
Treatment Group ECSWT ECSWT and Joint Mobs 
ECSWT and 
Exercise 
Age (years) 48 ± 10.9 47 ± 6.0 48 ± 8.8 
Gender 9 M, 16 FM 8 M, 17 FM 5 M, 20 FM 
Height (inches) 65.8 ± 4.5 67.0 ± 4.4 66.1 ± 3.1 
Weight (pounds) 192.8 ± 26.2 187.2 ± 24.0 190.5 ± 22.8 
BMI (kg/meter2) 31.3 29.3 30.7 
 
Abbreviations: BMI, Body Mass Index; M,male;FM,female. 
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Table 2.  Group Outcome Data for Pain (VAS) and Function (LEFS) 
 ECSWT (n=25) ECSWT and Jt Mobs (n=25) ECSWT and Exer (n=25) 
VAS At Rest    
Pre-treatment 34.8 ± 29.0 29.4 ± 33.6 45.8 ± 29.4 
Post-treatment 18.2 ± 24.4 9.5 ± 12.9 25.0 ± 27.4 
Within group change score 16.56 (7.6, 25.6) 19.76 (9.0, 30.5) 20.68 (6.2, 35.1) 
Within 
Between 
bT= 3.79, P= .001 
F= .147, P=.863 
bT=3.84, P= .001 
 
bT=2.97, P=.007 
 
VAS After Activity    
Pre-treatment 79.6 ± 13.5 78.7 ± 6.8 73.6 ± 18.5 
Post-treatment 31.5 ± 23.2 25.64 ± 22.7 42.4 ± 34.0 
Within group change score 48.0 (39.3, 56.7) a51.7 (40.9, 62.5) a33.0 (20.3, 45.6) 
Within 
Between 
bT = 11.39, P < .001 
aF=3.57, P=.033 
bT=11.46, P < .001 
 
bT=4.81, P < .001 
 
VAS Overall Improvement    
Pre-Treatment .00 ± .00 .00 ± .00 .00 ± .00 
Post-Treatment 63.4 ± 23.5 72.3 ± 30.7 52.2 ± 34.8 
Within 
Between 
bT= -13.46, P < .001 
F=2.81, P=.067 
bT= -11.76, P< .001 
 
bT=-7.48, P < .001 
 
LEFS (0-100)    
Pre-Treatment 46.9 ± 12.3 46.5 ± 15.0 40.4 ± 16.6 
Post-Treatment 61.1 ± 14.9 64.7 ± 16.5 54.9 ± 20.0 
Within group change score 13.6 (7.3, 20.0) 18.7 (12.26, 25.1) 14.5 (6.64, 22.4) 
Within 
Between 
bT= -4.76, P < .001 
F=.643, P=.529 
bT= -5.75, P < .001 
 
bT=-3.80, P= .001 
 
Abbreviations: VAS, Visual Analog Scale; LEFS, Lower Extremity Function Scale; ECSWT, Extracorporeal Shock Wave Therapy; Jt Mobs, joint 
mobilization; Exer, Exercise.  
a One-Way ANOVA Significant at P ≤ .05. 
b Independent T-test significant at P ≤ .05. Upper and lower bound means in parentheses at 95% confidence interval. 
 
 
Figure 3.  VAS scores for heel pain at rest by treatment group 
pre-treatment and post-treatment (mean pre and post VAS scores contained 
in text box within columns; pre-treatment VAS score ; post-treatment 
VAS score ;) 
 
Figure 4.  VAS scores for heel pain following activity by treatment group 
pre-treatment and post-treatment (mean pre and post VAS scores contained 
in text box within columns; pre-treatment VAS score ; post-treatment 
VAS score ;  significant between groups P<.05) 
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Figure 5.  VAS scores for overall improvement in heel pain by treatment 
group pre-treatment and post-treatment (mean pre and post VAS scores 
contained in text box within columns; pre-treatment VAS score ; 
post-treatment VAS score ;) 
4. Discussion 
It was hypothesized that ECSWT in combination with 
mobilization and exercise would have a greater effect on heel 
pain and function compared to ECSWT alone. All three 
groups had a clinically significant change in the VAS score 
for pain after activity, but the combination of ECSWT and 
joint mobilizations resulted in a statistically (p=.033) and 
clinically significant improvement when compared to the 
combination of ECSWT and exercise. This finding 
demonstrated a large effect size (d=.7) suggesting that there 
is a strong relationship between this treatment and the 
resulting reduction in pain. Joint mobilizations of the 
talocrural, subtalar, and first MTP joints when combined 
with ECSWT may be an effective treatment option in 
improving heel pain. Furthermore, all three groups improved 
in function as measured by the LEFS. Although this 
improvement was not statistically significant, each group 
demonstrated a clinically significant change in LEFS scores 
(post-treatment score changed by more than 9 points). 
Although not statistically significant, the greatest 
improvement in VAS and LEFS scores was consistently 
found in the ECSWT and joint mobilizations group. Subjects 
that were randomly allocated to this treatment group all 
received joint mobilizations whether or not it was necessary 
and joint stiffness was present. In the clinical setting, the 
healthcare provider would assess the patient and conclude 
whether joint mobilizations are appropriate. This would be 
based upon the assessment and clinical reasoning findings, 
and the healthcare provider’s determination that joint 
mobilizations were indicated. Therefore, the healthcare 
provider that is using ECSWT for the treatment of the PF 
patient should consider combining this with joint 
mobilizations to the talocrural, subtalar, and first MTP joints 
especially if ROM and accessory glide restrictions are noted 
during the assessment. This may, in turn, produce the most 
effective and greatest reduction in the patient’s heel pain. 
It should be highlighted that the inferences made above 
from the results of this study are limited by the fact that a 
control group was not used. The initial intent of this study, 
however, was to assess whether the use of ECSWT used in 
isolation would have the same effects as if ECSWT was 
combined with joint mobilizations or exercise. Based on the 
current results the consistent trends described above 
definitely suggests some positive findings and warrants 
further study examining the combinations of treatment using 
a different study design and control group. 
Studies examining the effects of mobilizations alone or 
compared to ECSWT are very limited. Cleland et al[9] 
reported that mobilizations directed to the hip, knee, and 
ankle combined with exercises were superior to the use of 
therapeutic modalities and exercise in improving heel pain 
and function in patients with PF. Cleland et al[9] used similar 
joint mobilizations to the talocrural and subtalar joints but 
did not include mobilizations of the first MTP joint. They 
mobilized several other joints including the hip, knee, 
inferior tibiofibular, and calcaneocuboid joints and also 
performed several soft tissue techniques. The different 
manual therapy techniques used by Cleland et al[9] varied 
from subject to subject with the treating practitioner using an 
impairments based manual therapy approach deciding what 
treatment to use based upon the assessment findings. Each 
subject in the mobilization and exercise group did not 
receive the same treatment technique making it difficult to 
conclude what produced the treatment effect. Future studies 
looking at ECSWT in combination with other interventions 
such as exercise or joint mobilizations should incorporate 
this impairment based treatment progression. This would 
allow the healthcare provider to use clinical reasoning to 
progress or modify the treatment regime according to the 
patient’s clinical presentation.  
It is possible that in the current study the combination of 
ECSWT and joint mobilizations to the talocrural, subtalar, 
and first MTP joints may have increased the joint mobility, 
improved the efficiency of the windlass mechanism, or had a 
segmental anti-nociceptive effect via stimulation of local 
mechanoreceptors thereby reducing strain on the plantar 
fascia. These treatments may have also improved the blood 
flow to the region, increased the elasticity of the tissue and 
stimulated connective tissue remodeling[21, 22, 24, 32, 37, 
41, 46]. These hypotheses may explain some of the benefits 
noted in our study with this combination of treatments but 
due to the current study design and the lack of a control 
group we must make this conclusion cautiously. 
Overall, the ECSWT treatment group and the ECSWT and 
exercise treatment group improved similarly suggesting that 
the addition of exercise was not consequential. A possible 
reason for this may have been due to a lack of compliance by 
subjects with the prescribed exercise program, or due to the 
actual exercises that were used as part of the intervention. 
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The therapeutic benefits, optimal exercise, intensity, speed, 
load and frequency of any stretching or strengthening 
program used in patients with PF is unclear, and there is no 
explicit explanation as to why or why not exercise may or 
may not help. The lack of improvement with exercise 
combined with ECSWT may also have been due to the lack 
of treatment and the possibility that three treatment sessions 
were not sufficient. Rompe et al[45] compared the effects of 
ECSWT to exercise and reported a greater improvement in 
acute heel pain with plantar fascial stretching compared to 
ECSWT. Rompe et al[44] also reported improved function 
and greater overall satisfaction in another study in patients 
who received therapeutic exercises compared to ECSWT. 
The contrasting findings from the current study may be 
attributed to the slightly different stretching parameters used 
(type of exercise and dosage). The stretches used by Rompe 
et al[44, 45] consisted of a static self-manual stretch to the 
plantar fascia completed in a sitting position compared to 
stretches for the gastrocnemius and soleus muscles and the 
plantar fascia completed in standing used in the current study. 
The use of the combination of stretching exercises for the 
plantar fascia and calf muscles in our study is consistent with 
what has been described in several previous studies[16, 19, 
22, 45, 54]. The length of time that the stretch was held also 
differed and was longer in our study (30 second holds, for 
three repetitions and repeated three times per day compared 
to 10 second holds, for 10 repetitions and repeated twice per 
day). The exercise program also differed in our study 
because the stretching exercises were also combined with 
strengthening exercises and this may have somehow 
impacted on the results. 
Other possible factors that may have influenced the results 
of this study is the treatment process. The ECSWT and joint 
mobilization group had the most direct hands on care. 
Rompe et al[44] raised this question in his study and whether 
the improved satisfaction of patients was related to the 
outcome of treatment or the process in which the treatment 
was carried out. The process of treatment can be described as 
the type and way in which the treatment is performed. The 
outcome of treatment can be described as the effectiveness of 
the intervention and the post-treatment effect. The greater 
improvement noted in our study with ECSWT and 
mobilizations may have been influenced by the process of 
treatment. With regards to the joint mobilizations, the patient 
may have reported benefit and positive feedback because of 
the touch and tactile stimulation used by the treating 
physiotherapist and the effect on the mechanoreceptors in the 
region.  
Lastly, while all groups improved from pre to post 
treatment, neither group achieved complete pain relief or 
restoration of function at three months post-treatment. This 
may be due to the fact that insufficient treatment was 
provided. Three treatments of ECSWT, manual therapy, or 
exercise may not have been sufficient and patients may have 
continued to improve if more treatment was provided. The 
frequency of ECSWT treatment in our study is consistent 
with the number of treatments proposed and used in most 
treatment protocols. 
Several studies have highlighted the long term benefit of 
ECSWT in the treatment of plantar heel pain. Our results are 
similar to these studies with the overall improvement at the 
three month follow up ranging from 52-72%. Gerdesmeyer 
et al[20] reported a significant improvement in VAS pain 
scores and functional scale scores at 4 months and 12 months 
follow up when compared to placebo. Two hundred and forty 
five subjects with chronic PF were randomly assigned either 
into the ECSWT treatment group or the placebo treatment 
group. The ECSWT treatment group received three 
treatments of 2000 shockwaves applied to the painful heel 
spaced two weeks apart. The placebo treatment group 
received ECSWT using the same parameters described but a 
placebo hand piece was used that prevented the actual 
transmission of the shockwaves. The overall success rates 
ranged from 61% in the ECSWT group as compared to  
42.2% in the control group. Similarly, we found a 63% 
improvement in our study for the ECSWT group when using 
the same number of shockwaves but spacing the treatment 
apart by one week. Chuckpaiwong et al[7] also reported 
similar success rates to those of the current study. At the 
three month follow up, they found a 70.7% reduction and at 
12 months a 77.2% improvement in VAS scores for pain 
with the first few steps in the morning, pain during daily 
activities and exercise, and an in functional scale outcome 
scores. 
Although different treatment parameters and different 
ECSWT generators have been used in the studies highlighted, 
the long term benefit and success rates of ECSWT appear to 
be consistent with the findings of our study. In several of the 
studies highlighted, despite the use of different ECSWT 
treatment parameters most patients improved over time. 
Some variability in the amount of improvement, however, 
has been reported in the literature regarding the success of 
ECSWT in patients with PF. This once again supports the 
use of this intervention in the treatment of heel pain but also 
reinforces the need for further research.  
As mentioned previously, a limitation to this study was the 
lack of a true control group. In order to determine the 
influence of ECSWT on the outcomes in this study, a group 
that received only joint mobilizations or exercise was needed. 
Future study designs that examine the effects of 
combinations of treatment with ECSWT must include 
appropriate controls in which the alternate intervention is 
used in isolation. Another limitation of the current study was 
the number of treatments used for the exercise group and not 
including a method for encouraging or monitoring 
compliance with exercise. Future studies should incorporate 
greater treatment frequency, a method of monitoring patient 
compliance, and a cut off whereby patients will not be 
included in the statistical analysis if a certain degree of 
compliance is not obtained. Finally, the number of 
treatments for the joint mobilization group and an 
impairments based progression should be implemented so 
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that only patients that require joint mobilizations receive this 
treatment in future studies. 
5. Conclusions 
All patients experienced improvements in function and 
heel pain with the use of ECSWT alone or in combination 
with joint mobilization or exercise. It appears that this 
modality has positive effects in the treatment of pain and 
function. The combination of ECSWT with joint 
mobilizations appears to be more effective than the 
combination of ECSWT with stretching and strengthening 
exercises to improve heel pain following activity. Treating 
practitioners may want to consider this treatment 
combination if the primary aggravating factor for heel pain is 
activity or post exercise. Further research is required that 
integrate the examination of combinations of treatments with 
ECSWT as this modality continues to be used more 
frequently clinically. Most healthcare providers do not treat 
solely with one modality or treatment approach so more 
research is required such as this study that examines 
combinations of treatments to simulate the actual clinical 
combinations used in the practical settings. Future studies 
must incorporate alternate designs to control for the 
limitations described in the current study. 
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